Generics 1

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Iron sucrose manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : Lebanon

Clear all

1 products found

iron sucrose

Ampoules 100 mg - 5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Lebanon
GMP approvals
Lebanon
Manufacturer #28777

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

IRON SUCROSE

Iron sucrose injection is an iron replacement product most commonly used to treat iron deficiency anemia in patients with chronic kidney disease in which damage is caused to the kidneys which may worsen over time and may cause the kidneys to stop working. The body produces red blood cells using iron. When the body is low on iron, it cannot produce the number of normal red blood cells needed for good health. This iron-shortage condition is called Iron Deficiency Anemia. The commonly prescribed treatment is Intravenous iron sucrose injection. Iron sucrose replenishes the iron in the blood to foster red blood cell production in patients of chronic kidney disease. Iron sucrose is sold under the brand name Venofer amongst others. Crookes Lab Ltd initially leads the Improvements relating to injectable iron preparations by 1953, they had filed the first patent. But it was Benger Lab Ltd, which created the first therapeutic preparations of iron sucrose and was approved for use in Europe as early as the 1950s. however, the first patent for use in medicine was not approved by the FDA till the early 2000s.

Usage:

Iron sucrose is available as a solution for injection for intravenous administration. Iron sucrose contains 20 mg of iron per milliliter of solution. A typical adult patient is prescribed an intake or dose of 600 mg of iron sucrose per week. This is administered in separate doses of 200–300 mg. At a dose of 20 g per liter, patients experience an increase in their hemoglobin levels. Each administration can take between fifteen to thirty minutes.

COST:

In India, the average cost of Iron sucrose injection ampoule is US$7 for a supply of 200 mg and a tablet with the same medicine cost USD0.2 per tablet. However, due to the availability of lot of manufacturers who can produce this product, this varies a lot.

How does it work?

Iron sucrose is an aqueous complex in sucrose of poly-nuclear iron hydroxide. After entering the human body, Iron sucrose dissociates itself into iron and sucrose. This iron is then transported as a complex with transferrin to target cells including erythroid precursor cells. As the cells mature into red blood cells, the iron in the erythroid precursor cells gets incorporated into hemoglobin.

Finding Iron Sucrose Manufacturers and Suppliers:

The best way to find and gain access to Iron Sucrose manufacturers and its suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Iron Sucrose can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All a patient needs to do to get started is to make use of the integrated search engine and start looking for suppliers or manufacturers of Iron Sucrose to work with and can fine-tune the search results using various filters too, letting us search for Iron Sucrose from specific countries.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation